Added to YB: 2023-12-13
Pitch date: 2023-12-13
ROIV [bullish]
Roivant Sciences Ltd.
+179.46%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
Market Cap
$20.9B
Pitch Price
$11.05
Price Target
N/A
Dividend
N/A
EV/EBITDA
-13.76
P/E
-24.90
EV/Sales
1.3K
Sector
Biotechnology
Category
N/A
Show full summary:
ROIVANT SCIENCES LTD ROIV
A summary for this pitch has not been created yet.
Read full article (0 min)